Company Filing History:
2 out of 3,539 
2 out of 2,489 
Years Active: 2022-2024
Title: The Innovative Contributions of Krisha McKee
Introduction
Krisha McKee is a notable inventor based in Columbia, MD, who has made significant contributions to the field of biomedical research. With a focus on developing neutralizing antibodies for HIV-1, her work has the potential to impact the treatment and prevention of this virus.
Latest Patents
Krisha McKee holds two patents that highlight her innovative approach to combating HIV-1. The first patent, titled "10E8 neutralizing antibody variants that bind to the MPER region of HIV-1 GP41 and their use," discloses neutralizing antibodies that specifically bind to HIV-1 Env. This patent also includes nucleic acids encoding these antibodies, vectors, and host cells. Additionally, it outlines methods for detecting HIV-1 using these antibodies and discusses their potential use in preventing and treating HIV-1 infections. The second patent, "Neutralizing antibodies to HIV-1 GP41 and their use," shares similar findings, emphasizing the importance of these antibodies in the fight against HIV-1.
Career Highlights
Throughout her career, Krisha McKee has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and Columbia University. Her experience in these institutions has allowed her to advance her research and contribute to significant scientific advancements.
Collaborations
Krisha has collaborated with notable colleagues, including Young Do Kwon and Ivelin Georgiev. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in the field of HIV treatment.
Conclusion
Krisha McKee's work in developing neutralizing antibodies for HIV-1 showcases her dedication to advancing medical science. Her patents and collaborations reflect her commitment to finding effective solutions for combating this global health issue.